Stanford University School of Medicine investigators have reported success in an early-phase clinical trial examining the safety, tolerability and feasibility of administering infusions of blood plasma from young donors to participants with mild to moderate Alzheimer’s disease. There were also some signs suggesting improvements in participants’ conditions.
from Dementia Big http://ift.tt/2zebrv7 via alcoholic dementia
http://ift.tt/2zmQPmq
No comments:
Post a Comment